Analysts Set Kura Oncology, Inc. (NASDAQ:KURA) Target Price at $27.69

Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has been assigned an average rating of “Moderate Buy” from the eight research firms that are currently covering the firm, reports. One equities research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year […]

Leave a Reply

Your email address will not be published.

Previous post PagSeguro Digital Ltd. (NYSE:PAGS) Receives $12.32 Consensus PT from Analysts
Next post Analysts Set Traeger, Inc. (NYSE:COOK) Price Target at $4.95